Citadel Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Citadel Advisors’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,400	Closed	-$530K	–	9282
2014 Q4	$530K	Sell	15,400 -2,300	-13%	-$75K	﹤0.01%	4656
2014 Q3	$528K	Sell	17,700 -6,600	-27%	-$140K	﹤0.01%	4545
2014 Q2	$487K	Buy	24,300 +12,600	+108%	+$289K	﹤0.01%	4434
2014 Q1	$318K	Sell	11,700 -6,200	-35%	-$165K	﹤0.01%	4958
2013 Q4	$371K	Sell	17,900 -11,300	-39%	-$213K	﹤0.01%	4376
2013 Q3	$532K	Sell	29,200 -19,700	-40%	-$356K	﹤0.01%	3748
2013 Q2	$813K	Buy	+48,900	New	+$781K	﹤0.01%	3375

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors's AUXL Position: Q3 2014 in Review

Citadel Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 4,697 shares — an estimated $99.6K sold.

Citadel Advisors first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $27.3M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

Citadel Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Citadel Advisors sold 4,697 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $99.6K.
Citadel Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
Citadel Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $27.3M in Q2 2013.
150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.